BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25993318)

  • 1. Alternatively spliced isoforms of WT1 control podocyte-specific gene expression.
    Lefebvre J; Clarkson M; Massa F; Bradford ST; Charlet A; Buske F; Lacas-Gervais S; Schulz H; Gimpel C; Hata Y; Schaefer F; Schedl A
    Kidney Int; 2015 Aug; 88(2):321-31. PubMed ID: 25993318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms' Tumor 1 Target Genes in Podocyte Differentiation and Maintenance.
    Dong L; Pietsch S; Tan Z; Perner B; Sierig R; Kruspe D; Groth M; Witzgall R; Gröne HJ; Platzer M; Englert C
    J Am Soc Nephrol; 2015 Sep; 26(9):2118-28. PubMed ID: 25556170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of podocyte Notch mediates early Wt1 glomerulopathy.
    Asfahani RI; Tahoun MM; Miller-Hodges EV; Bellerby J; Virasami AK; Sampson RD; Moulding D; Sebire NJ; Hohenstein P; Scambler PJ; Waters AM
    Kidney Int; 2018 Apr; 93(4):903-920. PubMed ID: 29398135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerulosclerosis Induced by Deficiency of Membrane-Associated Guanylate Kinase Inverted 2 in Kidney Podocytes.
    Shirata N; Ihara KI; Yamamoto-Nonaka K; Seki T; Makino SI; Oliva Trejo JA; Miyake T; Yamada H; Campbell KN; Nakagawa T; Mori K; Yanagita M; Mundel P; Nishimori K; Asanuma K
    J Am Soc Nephrol; 2017 Sep; 28(9):2654-2669. PubMed ID: 28539383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of MAGI2-RapGEF2-Rap1 signaling contributes to podocyte dysfunction in congenital nephrotic syndrome caused by mutations in MAGI2.
    Zhu B; Cao A; Li J; Young J; Wong J; Ashraf S; Bierzynska A; Menon MC; Hou S; Sawyers C; Campbell KN; Saleem MA; He JC; Hildebrandt F; D'Agati VD; Peng W; Kaufman L
    Kidney Int; 2019 Sep; 96(3):642-655. PubMed ID: 31171376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Analysis of Wilms' Tumor 1-Controlled Gene Expression in Podocytes Reveals Key Regulatory Mechanisms.
    Kann M; Ettou S; Jung YL; Lenz MO; Taglienti ME; Park PJ; Schermer B; Benzing T; Kreidberg JA
    J Am Soc Nephrol; 2015 Sep; 26(9):2097-104. PubMed ID: 25636411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of CMIP transcription by WT1 is relevant to podocyte health.
    Moktefi A; Zhang SY; Vachin P; Ory V; Henique C; Audard V; Rucker-Martin C; Gouadon E; Eccles M; Schedl A; Heidet L; Ollero M; Sahali D; Pawlak A
    Kidney Int; 2016 Dec; 90(6):1298-1311. PubMed ID: 27650733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
    Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
    Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel WT1 gene mutation in a three-generation family with progressive isolated focal segmental glomerulosclerosis.
    Benetti E; Caridi G; Malaventura C; Dagnino M; Leonardi E; Artifoni L; Ghiggeri GM; Tosatto SC; Murer L
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):698-702. PubMed ID: 20150449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PINCH1 is transcriptional regulator in podocytes that interacts with WT1 and represses podocalyxin expression.
    Wang D; Li Y; Wu C; Liu Y
    PLoS One; 2011 Feb; 6(2):e17048. PubMed ID: 21390327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurexin-1, a presynaptic adhesion molecule, localizes at the slit diaphragm of the glomerular podocytes in kidneys.
    Saito A; Miyauchi N; Hashimoto T; Karasawa T; Han GD; Kayaba M; Sumi T; Tomita M; Ikezumi Y; Suzuki K; Koitabashi Y; Shimizu F; Kawachi H
    Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R340-8. PubMed ID: 21048075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAGI-1 Interacts with Nephrin to Maintain Slit Diaphragm Structure through Enhanced Rap1 Activation in Podocytes.
    Ni J; Bao S; Johnson RI; Zhu B; Li J; Vadaparampil J; Smith CM; Campbell KN; Grahammer F; Huber TB; He JC; D'Agati VD; Chan A; Kaufman L
    J Biol Chem; 2016 Nov; 291(47):24406-24417. PubMed ID: 27707879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weighted Gene Correlation Network Analysis (WGCNA) Detected Loss of MAGI2 Promotes Chronic Kidney Disease (CKD) by Podocyte Damage.
    Zuo Z; Shen JX; Pan Y; Pu J; Li YG; Shao XH; Wang WP
    Cell Physiol Biochem; 2018; 51(1):244-261. PubMed ID: 30448842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
    Morrison AA; Viney RL; Saleem MA; Ladomery MR
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis.
    Guo JK; Menke AL; Gubler MC; Clarke AR; Harrison D; Hammes A; Hastie ND; Schedl A
    Hum Mol Genet; 2002 Mar; 11(6):651-9. PubMed ID: 11912180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
    Yang Y; Jeanpierre C; Dressler GR; Lacoste M; Niaudet P; Gubler MC
    Am J Pathol; 1999 Jan; 154(1):181-92. PubMed ID: 9916932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms.
    Klamt B; Koziell A; Poulat F; Wieacker P; Scambler P; Berta P; Gessler M
    Hum Mol Genet; 1998 Apr; 7(4):709-14. PubMed ID: 9499425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
    Guo N; Guo J; Su D
    Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.
    Sakairi T; Abe Y; Kopp JB
    Nephrol Dial Transplant; 2011 Sep; 26(9):2746-52. PubMed ID: 21378152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.